Last week saw a number of broker notes hitting the wires once again. Three buy ratings that investors might want to be aware of are summarised below.
Hereâs why brokers think investors ought to buy them next week:
Allkem Ltd (ASX: AKE)
According to a note out of Goldman Sachs, its analysts have reiterated their buy rating on this lithium minerâs shares with a slightly trimmed price target of $15.40. This follows the release of Allkemâs first-half results, which came in slightly ahead of expectations. Allkem remains Goldmanâs preferred lithium exposure due to its discount to peers and its optionality across the Americas and Australia on the largest lithium resource under its coverage. The Allkem share price ended the week at $12.36.
Harvey Norman Holdings Limited (ASX: HVN)
Another note out of Goldman Sachs reveals that it analysts have retained their buy rating on this retail giantâs shares with a trimmed price target of $4.70. Although Harvey Norman’s first-half results fell short of expectations, Goldman remains positive for a number of reasons. This includes its dirt cheap valuation compared to peers and its belief that the peak cash drag on franchisee support is behind it. The Harvey Norman share price was fetching $3.71 at Friday’s close.
Pointsbet Holdings Ltd (ASX: PBH)
Analysts at Bell Potter have retained their speculative buy rating on this sports betting companyâs shares with a reduced price target of $2.75. This follows a mixed half-year result with Pointsbet’s revenue beating expectations but its loss coming in greater than forecast. Nevertheless, the broker remains positive given its very large opportunity in the North American sports betting market. The Pointsbet share price ended the week at $1.43.
The post Top brokers name 3 ASX shares to buy next week appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now…
See The 5 Stocks
*Returns as of March 1 2023
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Give yourself a passive income boost with these ASX dividend shares: experts
- Here are the top 10 ASX 200 shares today
- Why is the Liontown share price roaring 12% higher today?
- What’s happening with ASX 200 lithium stocks this week?
- Buy these ASX 200 mining shares before they boom: experts
Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Harvey Norman and PointsBet. The Motley Fool Australia has positions in and has recommended Harvey Norman. The Motley Fool Australia has recommended PointsBet. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/rm8YRtT